Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
NTRB	NUTRIBAND INC	$63.80M	-96.40%	-85.90%	-161.26%	-3,534.70%	0.16	4.88	34.70%	-489.90%	-488.95%
NOTV	INOTIV INC	$67.33M	-51.40%	-11.30%	-7.85%	-8.20%	3.86	1.51	21.90%	-18.20%	-10.63%
ATRA	ATARA BIOTHERAPEUTICS INC	$42.59M	N/A	-63.90%	317.16%	-457.30%	-2.12	0.48	83.70%	-66.20%	-62.66%
PRLD	PRELUDE THERAPEUTICS INC	$44.10M	-89.20%	-69.30%	-105.23%	-83.60%	0.37	5.18	N/A	N/A	N/A
SION	SIONNA THERAPEUTICS INC	$543.61M	N/A	-51.90%	-35.18%	-76.50%	-0.12	14.49	N/A	N/A	N/A
TSHA	TAYSHA GENE THERAPIES INC	$436.65M	-110.60%	-51.50%	-66.50%	-179.50%	1.24	5.42	100.00%	-1,071.60%	-1,070.39%
NNNN	ANBIO BIOTECHNOLOGY	$914.93M	14.80%	13.70%	13.80%	44.90%	0.10	10.71	71.90%	29.00%	28.99%
PHIO	PHIO PHARMACEUTICALS CORP	$8.41M	-150.20%	-120.40%	-151.39%	986.50%	0.22	5.65	N/A	N/A	N/A
CTKB	CYTEK BIOSCIENCES INC	$370.48M	-2.90%	-2.30%	-0.69%	-1.10%	0.27	5.62	54.90%	-5.70%	-1.46%
AARD	AARDVARK THERAPEUTICS INC	$226.07M	N/A	-46.80%	-28.37%	-364.40%	-0.10	15.05	N/A	N/A	N/A
MYO	MYOMO INC	$115.13M	-35.60%	-20.10%	-18.47%	-54.60%	0.88	2.66	71.20%	-15.00%	-13.96%
GNLX	GENELUX CORP	$111.70M	-93.00%	-74.20%	-94.30%	-115.30%	0.31	4.68	N/A	N/A	N/A
NEUP	NEUPHORIA THERAPEUTICS INC	$8.80M	-13.40%	-10.10%	-19.98%	307.20%	0.32	2.06	100.00%	-433.30%	-483.45%
CLPT	CLEARPOINT NEURO INC	$389.89M	-62.50%	-40.80%	-65.59%	-131.80%	0.54	3.22	60.90%	-60.30%	-60.25%
BBIO	BRIDGEBIO PHARMA INC	$6.49B	N/A	-82.00%	-75.23%	-26.00%	-1.53	4.57	95.40%	-524.20%	-430.76%
GERN	GERON CORP	$751.56M	-48.50%	-27.10%	-23.18%	-23.40%	1.10	7.87	97.90%	-119.50%	-99.53%
NRSN	NEUROSENSE THERAPEUTICS LTD	$24.25M	N/A	-461.70%	-395.28%	388.00%	0.77	2.21	N/A	N/A	N/A
NIVF	NEWGENIVF GROUP LTD	$384.82k	N/A	-4.20%	-27.14%	-1.90%	-4.83	1.17	33.60%	-9.70%	-4.28%
ZBIO	ZENAS BIOPHARMA INC	$378.28M	-362.00%	-71.70%	-50.07%	-10,653.90%	0.18	6.21	100.00%	-3,139.80%	-3,131.18%
BLCO	BAUSCH & LOMB CORP	$3.98B	-5.60%	-2.70%	0.52%	0.80%	1.10	1.56	60.00%	-7.50%	1.26%
ITRM	ITERUM THERAPEUTICS PLC	$35.27M	N/A	-105.10%	-81.56%	-139.80%	-11.93	1.41	N/A	N/A	N/A
CGEN	COMPUGEN LTD	$112.82M	-24.40%	-12.30%	-10.24%	-43.50%	1.09	5.26	71.50%	-51.10%	-34.84%
SRDX	SURMODICS INC	$382.65M	-17.30%	-11.60%	-7.42%	-12.70%	0.48	5.14	73.40%	-16.30%	-9.11%
FOXO	FOXO TECHNOLOGIES INC	$2.51M	N/A	-57.20%	-94.60%	246.20%	6.84	0.09	38.70%	-332.70%	-209.70%
TAK	TAKEDA PHARMACEUTICAL CO LTD	$45.20B	1.50%	0.70%	3.28%	4.60%	1.05	1.01	65.50%	2.40%	8.40%
YMAB	Y-MABS THERAPEUTICS INC	$175.90M	-31.30%	-23.40%	-32.43%	-120.10%	0.30	4.16	82.60%	-33.80%	-35.58%
CPHI	CHINA PHARMA HOLDINGS INC	$6.90M	-63.20%	-32.20%	-46.42%	-58.20%	0.92	0.65	-43.80%	-104.60%	-101.18%
CTEV	CLARITEV CORP	$356.18M	-517.70%	-22.10%	-19.64%	-19.90%	341.97	1.02	74.10%	-127.00%	-103.84%
RMTI	ROCKWELL MEDICAL INC	$38.14M	-1.80%	-0.90%	1.72%	2.50%	0.82	2.63	17.20%	-0.50%	0.76%
HROW	HARROW INC	$895.47M	-35.80%	-6.10%	1.35%	1.10%	5.46	0.91	74.50%	-10.20%	1.12%
ADCT	ADC THERAPEUTICS SA	$125.84M	N/A	-46.70%	-44.50%	-83.80%	-2.59	3.82	91.60%	-222.80%	-151.71%
EVO	EVOTEC SE	$1.53B	N/A	N/A	N/A	N/A	1.13	2.03	N/A	N/A	N/A
NVNO	ENVVENO MEDICAL CORP	$64.01M	-51.30%	-48.20%	-54.81%	-57.40%	0.06	23.77	N/A	N/A	N/A
VCEL	VERICEL CORP	$2.10B	1.10%	0.70%	0.97%	1.00%	0.44	5.01	72.50%	1.20%	1.57%
SDGR	SCHRODINGER INC	$1.75B	-44.70%	-26.30%	-33.11%	-37.60%	0.99	3.45	62.60%	-83.40%	-82.96%
RNAC	CARTESIAN THERAPEUTICS INC	$256.95M	N/A	-10.30%	-9.65%	-20.90%	-19.78	12.34	100.00%	-124.40%	-111.27%
SXTP	60 DEGREES PHARMACEUTICALS INC	$3.52M	-166.00%	-130.30%	-193.53%	-291.20%	0.45	3.25	43.50%	-1,237.30%	-1,165.19%
EVAX	EVAXION BIOTECH A	$2.09M	N/A	-83.30%	-101.42%	-70.50%	-8.56	2.01	100.00%	-316.00%	-246.17%
ERAS	ERASCA INC	$393.74M	-40.10%	-33.60%	-34.31%	-39.50%	0.19	9.84	N/A	N/A	N/A
BIOA	BIOAGE LABS INC	$144.83M	N/A	N/A	N/A	N/A	0.10	13.68	N/A	N/A	N/A
TRVI	TREVI THERAPEUTICS INC	$671.52M	-58.40%	-52.50%	-47.31%	-76.10%	0.08	15.38	N/A	N/A	N/A
JYNT	JOINT CORP	$152.87M	-42.60%	-10.90%	-24.31%	-44.20%	2.88	1.59	86.60%	-9.90%	-9.53%
APDN	APPLIED DNA SCIENCES INC	$906.20k	-275.60%	-172.70%	-62.77%	-795.50%	0.27	4.73	39.30%	-631.30%	-228.18%
EPIX	ESSA PHARMA INC	$76.35M	-23.50%	-22.90%	-25.06%	-96.80%	0.02	67.17	N/A	N/A	N/A
PGEN	PRECIGEN INC	$391.08M	-215.70%	-115.60%	-103.45%	-374.10%	2.04	4.76	-8.70%	-3,216.20%	-3,261.71%
SLS	SELLAS LIFE SCIENCES GROUP INC	$141.72M	-325.50%	-144.50%	-311.24%	432.20%	1.05	1.72	N/A	N/A	N/A
XNCR	XENCOR INC	$592.85M	-31.90%	-22.60%	-20.82%	-18.20%	0.41	5.89	100.00%	-163.20%	-133.60%
STXS	STEREOTAXIS INC	$183.14M	-236.80%	-58.60%	-95.71%	-200.90%	5.81	1.22	54.20%	-94.20%	-89.33%
RCEL	AVITA MEDICAL INC	$183.71M	-337.90%	-71.50%	-94.76%	-58.30%	16.66	2.83	85.80%	-96.30%	-87.83%
ACTU	ACTUATE THERAPEUTICS INC	$202.15M	N/A	-389.60%	-5,284.79%	296.50%	88.44	1.05	N/A	N/A	N/A
CCCC	C4 THERAPEUTICS INC	$104.38M	-45.90%	-29.00%	-37.01%	-32.90%	0.64	5.70	100.00%	-259.60%	-259.27%
TECX	TECTONIC THERAPEUTIC INC	$368.97M	-30.90%	-28.30%	-19.44%	1,185.10%	0.05	22.92	N/A	N/A	N/A
ICCM	ICECURE MEDICAL LTD	$58.27M	-156.30%	-103.40%	-222.26%	-1,884.30%	0.82	1.95	44.10%	-465.50%	-476.94%
QNCX	QUINCE THERAPEUTICS INC	$44.88M	-115.80%	-42.50%	-52.93%	-88.60%	2.80	6.05	N/A	N/A	N/A
VIVS	VIVOSIM LABS INC	$2.76M	-346.30%	-187.50%	-1,364.72%	-567.00%	9.56	0.72	95.90%	-10,151.60%	-10,145.90%
AVXL	ANAVEX LIFE SCIENCES CORP	$701.78M	-37.50%	-34.10%	-41.99%	529.50%	0.12	9.45	N/A	N/A	N/A
CELU	CELULARITY INC	$37.55M	-119.50%	-25.40%	-56.82%	-27.90%	6.46	0.19	56.80%	-72.70%	-62.09%
ANAB	ANAPTYSBIO INC	$575.56M	-282.50%	-30.80%	-37.19%	-21.40%	11.41	8.25	100.00%	-125.70%	-125.66%
MGNX	MACROGENICS INC	$90.22M	-66.90%	-27.50%	-31.49%	-72.10%	1.26	3.92	91.80%	-44.70%	-43.28%
BCAX	BICARA THERAPEUTICS INC	$707.17M	-39.60%	-18.30%	-13.78%	1,726.90%	0.04	27.93	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$318.05M	5.80%	4.60%	5.09%	5.50%	0.17	21.88	100.00%	14.40%	13.82%
QTRX	QUANTERIX CORP	$204.74M	-11.40%	-9.40%	-10.45%	-10.60%	0.23	8.66	60.50%	-28.00%	-27.72%
SGMO	SANGAMO THERAPEUTICS INC	$157.30M	-275.30%	-90.10%	-175.73%	-184.00%	3.46	1.13	100.00%	-169.40%	-169.74%
RXST	RXSIGHT INC	$530.72M	-9.50%	-8.50%	-9.12%	-9.50%	0.12	12.68	71.90%	-17.90%	-17.84%
ATYR	ATYR PHARMA INC	$291.93M	-86.90%	-64.80%	-73.26%	-74.00%	0.30	7.80	N/A	N/A	N/A
MASS	908 DEVICES INC	$198.55M	-51.70%	-39.20%	-53.96%	-130.90%	0.39	4.10	50.10%	-121.10%	-121.56%
IPSC	CENTURY THERAPEUTICS INC	$46.21M	-66.90%	-33.60%	-55.84%	-41.70%	1.19	1.50	100.00%	-1,920.90%	-1,893.70%
RYTM	RHYTHM PHARMACEUTICALS INC	$3.65B	-762.80%	-45.70%	-53.80%	-81.10%	11.80	3.30	89.60%	-127.10%	-108.04%
MAIA	MAIA BIOTECHNOLOGY INC	$60.36M	-3,509.90%	-231.80%	-367.65%	670.80%	1.79	2.65	N/A	N/A	N/A
ESTA	ESTABLISHMENT LABS HOLDINGS INC	$980.87M	-210.40%	-28.60%	-25.10%	-17.00%	7.65	3.36	66.40%	-52.30%	-38.98%
VERO	VENUS CONCEPT INC	$1.72M	N/A	-61.60%	-107.45%	-45.60%	34.39	1.60	68.30%	-72.50%	-62.81%
FATE	FATE THERAPEUTICS INC	$119.18M	-49.50%	-36.60%	-46.31%	-37.60%	0.38	7.58	100.00%	-1,366.50%	-1,366.46%
OFIX	ORTHOFIX MEDICAL INC	$474.48M	-28.10%	-16.50%	-16.39%	-21.40%	0.80	2.71	67.20%	-17.80%	-13.83%
ACOG	ALPHA COGNITION INC	$119.03M	-156.80%	-95.50%	-30.67%	6,189.80%	0.22	15.00	N/A	N/A	N/A
LUCD	LUCID DIAGNOSTICS INC	$102.55M	-535.60%	-177.50%	-632.78%	-991.00%	4.70	1.07	-63.30%	-1,220.10%	-1,047.01%
SRTS	SENSUS HEALTHCARE INC	$74.06M	12.40%	11.20%	16.03%	25.70%	0.11	9.64	58.40%	15.90%	21.58%
RDNT	RADNET INC	$4.13B	0.30%	0.10%	3.16%	3.00%	2.39	2.13	13.60%	0.20%	4.85%
MGX	METAGENOMI INC	$56.45M	-30.10%	-21.00%	-29.09%	-27.20%	0.38	6.91	100.00%	-149.30%	-159.81%
COYA	COYA THERAPEUTICS INC	$101.19M	-42.70%	-37.90%	-38.50%	-6,359.70%	0.12	11.59	100.00%	-418.70%	-438.96%
BNTX	BIONTECH SE	$22.30B	-4.00%	-3.50%	-3.71%	-7.80%	0.12	10.18	79.40%	-27.90%	-26.56%
ATNM	ACTINIUM PHARMACEUTICALS INC	$46.17M	-96.40%	-45.40%	-55.63%	1,389.10%	1.35	9.14	N/A	N/A	N/A
RZLT	REZOLUTE INC	$223.98M	-70.30%	-62.40%	-70.15%	-85.30%	0.13	9.30	N/A	N/A	N/A
VYNE	VYNE THERAPEUTICS INC	$21.66M	-71.90%	-59.00%	-95.60%	-119.70%	0.28	4.47	100.00%	-6,974.50%	-6,973.88%
STTK	SHATTUCK LABS INC	$45.41M	-79.70%	-69.10%	-101.08%	-185.10%	0.14	9.08	100.00%	-1,533.00%	-1,532.96%
BLTE	BELITE BIO INC	$1.94B	-30.60%	-29.30%	-24.72%	-60.90%	0.04	24.31	N/A	N/A	N/A
NAMS	NEWAMSTERDAM PHARMA CO NV	$2.06B	-32.60%	-29.20%	-24.10%	1,904.80%	0.05	19.98	100.00%	-397.50%	-397.45%
INSM	INSMED INC	$11.85B	-447.00%	-52.70%	-59.08%	-45.80%	17.18	5.86	76.50%	-265.90%	-242.45%
AMLX	AMYLYX PHARMACEUTICALS INC	$410.94M	-106.30%	-87.90%	-108.80%	-160.80%	0.09	12.05	746.80%	17,205.70%	17,255.66%
KIDS	ORTHOPEDIATRICS CORP	$545.91M	-11.30%	-8.70%	-9.00%	-14.20%	0.36	6.19	72.80%	-19.10%	-18.33%
OCX	ONCOCYTE CORP	$82.08M	-768.10%	-97.10%	-218.81%	-1,534.10%	-3.86	1.62	39.30%	-3,239.00%	-3,234.56%
BDTX	BLACK DIAMOND THERAPEUTICS INC	$92.93M	-70.40%	-50.40%	-68.26%	-64.00%	0.47	4.92	N/A	N/A	N/A
SERA	SERA PROGNOSTICS INC	$83.63M	-51.30%	-37.20%	-34.78%	-54.90%	0.25	2.02	8.70%	-28,685.20%	-28,665.22%
MXCT	MAXCYTE INC	$249.70M	-18.90%	-16.50%	-18.35%	-18.50%	0.16	10.88	81.60%	-106.30%	-106.29%
CRBU	CARIBOU BIOSCIENCES INC	$71.99M	-50.20%	-41.50%	-52.75%	-46.40%	0.24	7.16	100.00%	-1,491.90%	-1,492.04%
BIVI	BIOVIE INC	$20.67M	-141.00%	-98.30%	-94.41%	1,004.70%	0.07	16.94	N/A	N/A	N/A
UNCY	UNICYCIVE THERAPEUTICS INC	$65.84M	N/A	-90.40%	-485.67%	257.30%	3.26	1.28	N/A	N/A	N/A
NRIX	NURIX THERAPEUTICS INC	$724.24M	-47.50%	-36.10%	-39.66%	-50.10%	0.28	6.26	100.00%	-369.40%	-369.08%
KROS	KEROS THERAPEUTICS INC	$554.40M	0.70%	0.70%	1.95%	35.20%	0.08	19.29	100.00%	2.00%	6.78%
FBRX	FORTE BIOSCIENCES INC	$41.99M	-132.00%	-103.10%	-67.60%	-1,017.80%	0.17	6.76	N/A	N/A	N/A
BDRX	BIODEXA PHARMACEUTICALS PLC	$0.00	-88.10%	-45.20%	-59.66%	3,668.10%	0.78	1.75	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	661	-1.90%	-9.32%	+2.11%	-77.89%	-159.67x	4.11x	-21.63%	-3.01%	+4.31%	+117.15%	Strong Buy
Diagnostics & Research	58	-1.82%	-1.68%	+1.10%	-27.12%	30.54x	3.32x	-9.95%	+6.16%	+11.85%	+24.70%	Buy
Drug Manufacturers - General	18	-1.71%	-7.73%	-2.94%	-10.66%	36.28x	5.66x	+50.81%	+9.81%	+16.71%	+64.13%	Buy
Drug Manufacturers - Specialty & Generic	78	+11.46%	+24.26%	+37.21%	-44.14%	4.37x	2.16x	+10.84%	+5.55%	+11.97%	+47.21%	Buy
Healthcare Plans	11	-1.10%	-1.32%	-12.70%	-17.24%	15.61x	2.29x	+17.32%	+5.46%	+12.61%	+24.91%	Buy
Health Information Services	55	+0.01%	-1.23%	+3.09%	-69.80%	45.44x	3.60x	+9.15%	+3.87%	+8.90%	+56.84%	Buy
Medical Care Facilities	48	+0.29%	+1.20%	+2.81%	-13.81%	15.73x	4.39x	-79.34%	+6.65%	+14.02%	+20.85%	Buy
Medical Devices	142	+0.75%	+1.23%	+4.30%	-16.99%	37.31x	3.97x	+8.00%	+8.35%	+9.21%	+31.00%	Strong Buy
Medical Distribution	10	+0.25%	-1.88%	+4.46%	+22.12%	27.32x	1,280.97x	-0.01%	+3.61%	+22.85%	+7.41%	Buy
Medical Instruments & Supplies	55	-0.60%	-0.13%	+0.08%	-41.35%	42.59x	3.69x	+10.11%	+8.34%	+10.85%	+28.79%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top healthcare stock out of 1136 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: B.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 26, which is equal to the healthcare sector average of 26. It passed 8 out of 33 due diligence checks and has average fundamentals. Protalix Biotherapeutics has seen its stock return 37.6% over the past year, overperforming other healthcare stocks by 93 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 772.09% from Protalix Biotherapeutics's current stock price of $1.72.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Ptc Therapeutics (NASDAQ:PTCT)

Ptc Therapeutics (NASDAQ:PTCT) is the #2 top healthcare stock out of 1136 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ptc Therapeutics (NASDAQ:PTCT) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Ptc Therapeutics (NASDAQ:PTCT) has a Due Diligence Score of 38, which is 12 points higher than the healthcare sector average of 26. It passed 12 out of 33 due diligence checks and has average fundamentals. Ptc Therapeutics has seen its stock return 42.45% over the past year, overperforming other healthcare stocks by 98 percentage points.

Ptc Therapeutics has an average 1 year price target of $61.85, an upside of 39.83% from Ptc Therapeutics's current stock price of $44.23.

Ptc Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Ptc Therapeutics, 46.15% have issued a Strong Buy rating, 15.38% have issued a Buy, 23.08% have issued a Hold, while 0% have issued a Sell rating, and 15.38% have issued a Strong Sell.

3. Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) is the #3 top healthcare stock out of 1136 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: C, Sentiment: B, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 42, which is 16 points higher than the healthcare sector average of 26. It passed 15 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 26.95% over the past year, overperforming other healthcare stocks by 83 percentage points.

Phibro Animal Health has an average 1 year price target of $21.50, a downside of -4.32% from Phibro Animal Health's current stock price of $22.47.

Phibro Animal Health stock has a consensus Sell recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 0% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 50% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 70 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Jade Biosciences (NASDAQ:JBIO)

Jade Biosciences (NASDAQ:JBIO) has an annual dividend yield of 27.75%, which is 25 percentage points higher than the healthcare sector average of 2.45%.

Jade Biosciences's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 13.16%, which is 11 percentage points higher than the healthcare sector average of 2.45%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 32.4% indicates that its high dividend yield is sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 10.6%, which is 8 percentage points higher than the healthcare sector average of 2.45%.

Siga Technologies's dividend payout ratio of 88.2% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.43% in the last day, and down -2.62% over the last week. Iovance Biotherapeutics was the among the top losers in the healthcare sector, dropping -44.79% yesterday.

Iovance Biotherapeutics shares are trading lower after the company reported worse-than-expected Q1 financial results. Also, HC Wainwright lowered its price target on the spot from $32 to $20.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Biote (NASDAQ:BTMD)

Biote (NASDAQ:BTMD) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Biote has a valuation score of 29, which is 13 points higher than the healthcare sector average of 16. It passed 2 out of 7 valuation due diligence checks.

Biote's stock has dropped -36% in the past year. It has overperformed other stocks in the healthcare sector by 20 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 8.86% in the past year. It has overperformed other stocks in the healthcare sector by 65 percentage points.

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 14, which is -2 points higher than the healthcare sector average of 16. It passed 1 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates IRWD a Valuation Rating of "A".

Ironwood Pharmaceuticals's stock has dropped -89.48% in the past year. It has underperformed other stocks in the healthcare sector by -34 percentage points.

Are healthcare stocks a good buy now?

52.64% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 55.23% over the next year.

5.2% of healthcare stocks have a Zen Rating of A (Strong Buy), 10.88% of healthcare stocks are rated B (Buy), 45.22% are rated C (Hold), 26.72% are rated D (Sell), and 11.97% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 3.99x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Protalix Biotherapeutics (NYSEMKT:PLX)

2. Ptc Therapeutics (NASDAQ:PTCT)

3. Phibro Animal Health (NASDAQ:PAHC)

1. Jade Biosciences (NASDAQ:JBIO)

2. Select Medical Holdings (NYSE:SEM)

3. Siga Technologies (NASDAQ:SIGA)

1. Biote (NASDAQ:BTMD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Protalix Biotherapeutics (NYSEMKT:PLX)

2. Ptc Therapeutics (NASDAQ:PTCT)

3. Phibro Animal Health (NASDAQ:PAHC)

1. Jade Biosciences (NASDAQ:JBIO)

2. Select Medical Holdings (NYSE:SEM)

3. Siga Technologies (NASDAQ:SIGA)

1. Biote (NASDAQ:BTMD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.